12 signals · News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Auto-generated from public signals — AI summary pending. Based on 3 recent signals.
Gilead Sciences rises as analyst upgrade adds to HIV franchise momentum Quiver Quantitative
Gilead Sciences stock rating upgraded to Buy by HSBC on HIV outlook Investing.com
OP Asset Management Ltd Acquires Shares of 256,653 Gilead Sciences, Inc. $GILD MarketBeat
OP Asset Management Ltd Acquires Shares of 256,653 Gilead Sciences, Inc.
Biopharmaceutical focused on antiviral drugs.
Based on 12 signals across 1 source · snapshot 8 Jul 2026
Moderate — directional but may shift as more signals arrive.
Based on 12 signals across 1 source
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.